Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persica vs chlorhexidine for prevention of ventilator-associated pneumonia in ICU patients
IRCT2017022032676N1Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of miswak extract and chlorhexidine in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Mazandaran University of Medical Sciences. Started Sep 2015; status: completed.
02
Drugs
miswak extractchlorhexidine
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT2017022032676N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017022032676N1.